Yingrui Shi

2.0k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Yingrui Shi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingrui Shi has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingrui Shi's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Yingrui Shi is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Head and Neck Cancer Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Yingrui Shi collaborates with scholars based in China, United States and Thailand. Yingrui Shi's co-authors include Qianjin Liao, Linda Oyang, Longzheng Xia, Jinguan Lin, Yujuan Zhou, Shiming Tan, Pin Yi, Shan Rao, Jiaxin Liang and Lu Tang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Psychopharmacology.

In The Last Decade

Yingrui Shi

24 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cancer metabolic reprogramming and immune response

2021 799 citations Longzheng Xia, Linda Oyang et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Yingrui Shi

Since Specialization

Citations

This map shows the geographic impact of Yingrui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingrui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingrui Shi more than expected).

Fields of papers citing papers by Yingrui Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingrui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingrui Shi. The network helps show where Yingrui Shi may publish in the future.

Co-authorship network of co-authors of Yingrui Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yingrui Shi. A scholar is included among the top collaborators of Yingrui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingrui Shi. Yingrui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quercetin Alleviates Breast Cancer‐Related Depression by Inhibiting Neutrophil Extracellular Traps via Inhibition of Sphingosine 1‐Phosphate/Sphingosine 1‐Phosphate Receptor Axis 2025 ·Phytotherapy Research ·Qing Zhu, Ye Tao, Yuanshan Han, Ying He, (unknown), Hui Yang, Yun Chen, Yingrui Shi	2
2	Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination 2024 ·International Journal of Biological Sciences ·Longzheng Xia, Jinguan Lin, Mingjing Peng, Xianjie Jiang, (unknown), (unknown), Wenlong Zhang, Shizhen Li, Jiewen Wang, Linda Oyang, Shiming Tan, (unknown), Nayiyuan Wu, Yanyan Tang, Xia Luo, (unknown), Yingrui Shi, Qianjin Liao, Yujuan Zhou	8
3	Quercetin inhibits neuronal Ferroptosis and promotes immune response by targeting lipid metabolism-related gene PTGS2 to alleviate breast cancer-related depression 2024 ·Phytomedicine ·Qing Zhu, Yuanshan Han, Ying He, Meng Pan, (unknown), Hui Yang, Gefei He, (unknown), Yingrui Shi	28
4	Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways 2023 ·Psychopharmacology ·Dehua Liao, (unknown), Yi Wu, Yun Chen, Ni Liu, Jingyi Tang, (unknown), Yingrui Shi	31
5	Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus 2023 ·International Immunopharmacology ·Dehua Liao, Chaoyi Liu, Shanshan Chen, Fen Liu, (unknown), (unknown), Yingrui Shi	15
6	Kaempferol Improves Breast Cancer-Related Depression through the COX-2/PGE2 Pathway 2023 ·Frontiers in Bioscience-Landmark ·Qing Zhu, Yuanshan Han, Ying He, (unknown), Hui Yang, Yun Chen, Yingrui Shi	13
7	Organoids: opportunities and challenges of cancer therapy 2023 ·Frontiers in Cell and Developmental Biology ·Xianjie Jiang, Linda Oyang, Peng Qiu, Qiang Liu, Xuemeng Xu, Nayiyuan Wu, Shiming Tan, Wenjuan Yang, Yaqian Han, Jinguan Lin, Longzheng Xia, Mingjing Peng, Yanyan Tang, Xia Luo, Min Su, Yingrui Shi, Yujuan Zhou, Qianjin Liao	16
8	Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study 2022 ·BMC Pulmonary Medicine ·(unknown), (unknown), Xu Ye, Kun Xiong, (unknown), Yingrui Shi	10
9	The function of prohibitins in mitochondria and the clinical potentials 2022 ·Cancer Cell International ·Linda Oyang, Jian Li, Xianjie Jiang, Jinguan Lin, Longzheng Xia, Lixia Yang, Shiming Tan, Nayiyuan Wu, Yaqian Han, Yiqing Yang, Xia Luo, Jinyun Li, Qianjin Liao, Yingrui Shi, Yujuan Zhou	18
10	Neutrophil-to-lymphocyte ratio trend: A novel prognostic predictor in patients with nasopharyngeal carcinoma receiving radiotherapy 2022 ·The International Journal of Biological Markers ·Pei Yang, (unknown), Hao Liang, (unknown), Bassem Youssef, Hesham Elhalawani, Meizhen Li, Fengbo Tan, Yi Jin, Hekun Jin, Hong Zhu, Abdallah Mohamed, (unknown), Danita Kannarunimit, Yingrui Shi, Hui Wang, Clifton D. Fuller	4
11	The cancer metabolic reprogramming and immune response breakdown → 2021 ·Molecular Cancer ·Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Yaqian Han, Nayiyuan Wu, Pin Yi, Lu Tang, Qing Pan, Shan Rao, Jiaxin Liang, Yanyan Tang, Min Su, Xia Luo, Yiqing Yang, Yingrui Shi, Hui Wang, Yujuan Zhou, Qianjin Liao	799
12	Radiological Prediction Model of Lung Radiation Pneumonitis Based on Dose Line Segmentation 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Pei Yang, (unknown), (unknown), Yi Jin, Jingyi Cheng, Hesham Elhalawani, (unknown), (unknown), Abdallah Mohamed, Yingrui Shi, (unknown), Clifton D. Fuller	2
13	RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer 2020 ·Frontiers in Oncology ·Shiming Tan, Pin Yi, Heran Wang, Longzheng Xia, Yaqian Han, Hui Wang, (unknown), Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Linda Oyang, Jiaxin Liang, Jinguan Lin, Min Su, Yingrui Shi, Qianjin Liao, Yujuan Zhou	21
14	The functions and mechanisms of prefoldin complex and prefoldin-subunits 2020 ·Cell & Bioscience ·Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, (unknown), Yujuan Zhou, Qianjin Liao	30
15	MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma 2020 ·Journal of Cancer ·Yutong Tian, Lu Tang, Pin Yi, Qing Pan, Yaqian Han, Yingrui Shi, Shan Rao, Shiming Tan, Longzheng Xia, Jinguan Lin, Linda Oyang, Yanyan Tang, Jiaxin Liang, Xia Luo, Qianjin Liao, Hui Wang, Yujuan Zhou	26
16	High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma 2019 ·Journal of Cancer ·Yaqian Han, Qianjin Liao, Heran Wang, Shan Rao, Pin Yi, Lu Tang, Yutong Tian, Linda Oyang, Hui Wang, Yingrui Shi, Yujuan Zhou	12
17	The Role of Immunotherapy in Nasopharyngeal Carcinoma in the Future: Evidence from the Era of Conventional Radiotherapy 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Yu Zhao, Pan‐Chyr Yang, Hesham Elhalawani, Abdallah Mohamed, Yi Jin, (unknown), Yingrui Shi, (unknown), Weiye Deng, Chao Chen, Ni Zeng, (unknown), Clifton D. Fuller	1
18	An imaging/biology correlation study between radiomics features and anaplastic lymphoma kinase (ALK) mutational status in a uniform Chinese cohort of locally advanced lung adenocarcinomas. 2018 ·Journal of Clinical Oncology ·(unknown), Pei Yang, Dennis Mackin, Hesham Elhalawani, Zijian Zhang, (unknown), Yingrui Shi, Hui Wang, Hekun Jin, Abdallah Mohamed, Laurence E. Court, Clifton D. Fuller, Lin Wu	1
19	Discrimination of Epstein-Barr Virus Status in NPC Using CT-Derived Radiomics Features: Linking Imaging Phenotypes to Tumor Biology 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Pei Yang, Dennis Mackin, Chao Chen, Abdallah Mohamed, Hesham Elhalawani, Yingrui Shi, (unknown), Stefania Volpe, Laurence E. Court, (unknown), Clifton D. Fuller	1
20	Abscopal antitumor immune effects of magnet-mediated hyperthermia at a high therapeutic temperature on Walker-256 carcinosarcomas in rats 2014 ·Oncology Letters ·Hui Wang, Li Zhang, Yingrui Shi, (unknown), Guirong Wang, Xiao Li, Weiwei Ouyang, Jumei Zhou, Lingyun Zhao, Xiaowen Wang, Xiaodong Zhang, Fuping Gao, Jingshi Liu, Junming Luo, Jintian Tang	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact